Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More

Posted byZacks Equity Research Leave a comment on Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More

Regulatory and pipeline updates from Regeneron (REGN) and Incyte (INCY), among others, have been in focus in the biotech industry over the past week.

Leave a comment

Your email address will not be published. Required fields are marked *